Literature DB >> 23748201

Primary Myoclonus-Dystonia: A Diagnosis Often Missed in Children.

Debabrata Ghosh1, Shalaka Indulkar.   

Abstract

Primary myoclonus-dystonia is a childhood-onset autosomal-dominant movement disorder with myoclonic jerks and dystonia. The authors report 9 children (4 boys, 5 girls) with myoclonus-dystonia from 8 families seen over a 4-year period at Cleveland Clinic. The mean age of onset of symptoms was 2.8 years, but the diagnosis was made at a mean of 7.3 years. Myoclonus was the presenting symptom in 8 children. A known pathogenic mutation in the ε-sarcoglycan gene (SGCE) was identified in 4 of the 9 children, and 2 other children had novel mutations in the same gene. Good response to trihexyphenidyl and clonazepam was seen. Two patients underwent deep brain stimulation surgery of the bilateral globus pallidus pars interna. In 7 children, the diagnosis of myoclonus-dystonia was not considered by the referring child neurologists, which led to extensive investigations and a delay in the final diagnosis. In this report, the authors highlight the need for increased awareness of this entity among child neurologists.

Entities:  

Keywords:  clonazepam; deep brain stimulation; dystonia; myoclonus; trihexyphenidyl; ε-sarcoglycan mutation

Year:  2013        PMID: 23748201     DOI: 10.1177/0883073813488677

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

1.  Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation.

Authors:  Kristoffer Haugarvoll; Charalampos Tzoulis; Gia T Tran; Bjørn Karlsen; Bernt A Engelsen; Per M Knappskog; Laurence A Bindoff
Journal:  J Neurol       Date:  2013-12-03       Impact factor: 4.849

2.  Sleep-Related Eating Disorder (SRED): Paradoxical Effect of Clonazepam.

Authors:  Debabrata Ghosh; Abigail M Petrecca; Abdul Latif Khuhro
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

Review 3.  ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.

Authors:  Ana Cazurro-Gutiérrez; Anna Marcé-Grau; Marta Correa-Vela; Ainara Salazar; María I Vanegas; Alfons Macaya; Àlex Bayés; Belén Pérez-Dueñas
Journal:  Mol Neurobiol       Date:  2021-04-22       Impact factor: 5.590

Review 4.  Clinical Management of Dystonia in Childhood.

Authors:  Quyen N Luc; Jyes Querubin
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.930

Review 5.  Uncommon applications of deep brain stimulation in hyperkinetic movement disorders.

Authors:  Kara M Smith; Meredith A Spindler
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.